Delayed
Japan Exchange
14:30:00 08/07/2025 HKT
5-day change
1st Jan Change
1,016.00 JPY
-0.15%
-1.69%
-7.00%
Asahi Kasei Buys Back 27 Billion Yen in Shares last December 2024
Published on 10/01/2025 at 18:59,
updated on 10/01/2025 at 19:01
Macquarie Starts Asahi Kasei at Outperform with 1,400 Yen Price Target
07-07
MT
Cyto-Facto Inc. announced that it has received ¥1.2 billion in funding from MPower Partners GP Limited, Asahi Kasei Corporation, FUJIFILM Holdings Corporation, Sumitomo Corporation
06-13
CI
Inventiva Announces the Appointment of Renée Aguiar-Lucander to Its Board of Directors
06-11
CI
Asahi Kasei Launches New Series of Sunfort?? Dry Film Photoresist as Material for Back-End Processing of Advanced Semiconductor Packaging Used in Ai Servers
05-29
CI
Asahi Kasei Corp. Resolves to Discontinue Its Businesses for Methyl Methacrylate Monomer, Cyclohexyl Methacrylate Resinomer) Resinomer, and to Reconfiguration of Acetonitrile Supply Framework for Acetonitrile
05-27
CI
Asahi Kasei Corp - Discontinuation Of MMA, CHMA, PMMA Resin, And SB Latex Businesses, And Reconfiguration Of Acetonitrile Supply Framework
05-27
RE
China slaps anti-dumping duties on plastics from US, EU, Japan, Taiwan
05-18
RE
China slaps anti-dumping duties on plastics from US, EU, Japan, Taiwan
05-18
RE
Asahi Kasei Corporation Provides Earnings Guidance for Q1-Q2 and Full Year Ending March 31, 2026
05-09
CI
Asahi Kasei, Nobian, Furuya Metal, and Mastermelt Commences Joint Project to Recycle Metals from Electrolyzer Components - Signaling A Major Milestone Towards Circularity in the Chlor-Alkali Industry
04-23
CI
Asahi Kasei Establishes Asahi Kasei Life Science to Operate Its Bioprocess Business
04-08
CI
Power to Hydrogen, LLC announced that it has received $20 million in funding from a group of investors
03-27
CI
Quemix Tests Quantum Error Detection Using Hybrid System
03-12
MT
Asahi Kasei to Acquire 9.88% Stake in The Global for Business Alliance
03-12
MT
Asahi Kasei Corp - Notice Regarding Acquisition Of Shares Of Global Ltd. (Securities Code 3271) By Asahi Kasei Homes Corp. To Qualify As Act Of Buying Up
03-11
RE
Quemix Inc. Announces Results of Collaborative Research with Asahi Kasei Corporation, the University of Tokyo, and A Research Group At the National Institutes for Quantum Science and Technology
03-11
CI
Veloxis Pharmaceuticals and Asahi Kasei Company Receives Approval from USAN for "Pegrizeprument" as Nonproprietary Name for VEL-101
02-25
CI
Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 1, 2024.
02-13
CI
Asahi Kasei Corporation's Equity Buyback announced on November 1, 2024, has closed with 28,180,100 shares, representing 2.04% for ¥29,999.95 million.
02-12
CI
Asahi Kasei to Absorb Subsidiary Asahi Kasei Epoxy in Merger
02-06
MT
Asahi Kasei Corp - Asahi Kasei To Absorb Wholly Owned Subsidiary Asahi Kasei Epoxy Through Simplified Merger
02-05
RE
Asahi Kasei Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2025
02-05
CI
Asahi Kasei Receives Governmental Support to Expand Manufacturing Capacity for Green Hydrogen Production Equipment in Japan
01-15
CI
Asahi Kasei Buys Back 27 Billion Yen in Shares last December 2024
01-10
MT
Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 1, 2024.
01-09
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
3407: Dynamic Chart
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
More about the company
Last Close Price
1,017.50 JPY
Average target price
1,329.17 JPY
Spread / Average Target
+30.63%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions